This trial will compare the Emsella Chair therapy to a Sham treatment to see if electromagnetic technology is effective in treating chronic pelvic pain. Subjects will receive 2 treatments per week for 4 weeks.
1 Primary · 14 Secondary · Reporting Duration: Treatment durability will be assessed 4 weeks after the primary endpoint; week 12 of the study
2 Treatment Groups
Emsella Chair Active Treatment
1 of 2
Emsella Sham Treatment
1 of 2
60 Total Participants · 2 Treatment Groups
Primary Treatment: Emsella Chair Active Treatment · Has Placebo Group · N/A
Who is running the clinical trial?
Age 18 - 80 · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is enrollment still available for this study?
"Indeed, information accessible on clinicaltrials.gov confirms that this medical trial is still recruiting patients; it was initially posted on July 13th 2020 and last updated October 1st 2022. There is a need to recruit 60 individuals from one particular clinic." - Anonymous Online Contributor
Is participation in this research endeavor open to individuals aged 55 or older?
"Participants must have surpassed the age of consent and not yet reached their eightieth birthday in order to be considered for this medical trial." - Anonymous Online Contributor
How many participants are being recruited for this clinical trial?
"Affirmative. The information posted on clinicaltrials.gov states that this research endeavour is actively enrolling participants, with the trial having first been made public on July 13th 2020 and last updated in October 1st 2022. It is seeking sixty volunteers from one location for participation." - Anonymous Online Contributor
Do I meet the criteria to participate in this research endeavor?
"This medical trial seeks 60 volunteers, aged 18-80, that are suffering from non-cyclical pelvic pain. Eligible participants must be able to read and understand the study's informed consent form; provide written and dated confirmation of their understanding; comply with all protocol requirements (including completion of associated questionnaires); refrain from starting any new treatments for CPP during the treatment period; maintain a steady dosage for current medications throughout the course of the trial; and if applicable, practice approved birth control methods such as oral contraceptives or surgically sterilized partners." - Anonymous Online Contributor